Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tatsuya Minami

Showing results (51-60 of 68) with videos related to

Pageof 7
Sort By:
Gastro Hep Advances|August 12, 2024
Machine Learning-Based Personalized Prediction of Hepatocellular Carcinoma Recurrence After Radiofrequency AblationMasaya Sato, Ryosuke Tateishi, Makoto Moriyama, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|May 3, 2025
Comparable outcomes among etiologies in early-stage hepatocellular carcinoma: Analysis of a nationwide registry in JapanKazuya Okushin, Ryosuke Tateishi, Shinya Hirakawa, et al.
Journal of Gastroenterology|July 5, 2022
Current status of primary liver cancer and decompensated cirrhosis in Japan: launch of a nationwide registry for advanced liver diseases (REAL)Kazuya Okushin, Ryosuke Tateishi, Arata Takahashi, et al.
Liver Cancer|October 11, 2023
Proton Beam Therapy versus Radiofrequency Ablation for Patients with Treatment-Naïve Single Hepatocellular Carcinoma: A Propensity Score AnalysisYuta Sekino, Ryosuke Tateishi, Nobuyoshi Fukumitsu, et al.
Plos One|October 8, 2013
Changes in risk of immediate adverse reactions to iodinated contrast media by repeated administrations in patients with hepatocellular carcinomaNaoto Fujiwara, Ryosuke Tateishi, Masaaki Akahane, et al.
Scientific Reports|February 3, 2024
The impact of COVID-19 on the diagnosis and treatment of HCC: analysis of a nationwide registry for advanced liver diseases (REAL)Kazuya Okushin, Ryosuke Tateishi, Shinya Hirakawa, et al.
Journal of Hepatology|March 1, 2015
Sarcopenia, intramuscular fat deposition, and visceral adiposity independently predict the outcomes of hepatocellular carcinomaNaoto Fujiwara, Hayato Nakagawa, Yotaro Kudo, et al.
Journal of Gastroenterology and Hepatology|November 6, 2018
Liver stiffness measurements in chronic hepatitis C: Treatment evaluation and risk assessmentRyo Nakagomi, Ryosuke Tateishi, Ryota Masuzaki, et al.
Plos One|January 17, 2025
Retrospective evaluation of a novel ultrasound-based imaging analysis software for predicting radiofrequency ablation areasMasaya Sato, Ryosuke Tateishi, Yogev Zohar, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|May 30, 2025
Predicting the risk of developing diabetes in steatotic liver disease using controlled attenuation parameter in a health checkup populationTakuma Nakatsuka, Yutaka Yamaji, Ryosuke Tateishi, et al.
Pageof 7

Showing results (51-60 of 68) with videos related to

Sort By:
Pageof 7
Gastro Hep Advances|August 12, 2024
Machine Learning-Based Personalized Prediction of Hepatocellular Carcinoma Recurrence After Radiofrequency AblationMasaya Sato, Ryosuke Tateishi, Makoto Moriyama, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|May 3, 2025
Comparable outcomes among etiologies in early-stage hepatocellular carcinoma: Analysis of a nationwide registry in JapanKazuya Okushin, Ryosuke Tateishi, Shinya Hirakawa, et al.
Journal of Gastroenterology|July 5, 2022
Current status of primary liver cancer and decompensated cirrhosis in Japan: launch of a nationwide registry for advanced liver diseases (REAL)Kazuya Okushin, Ryosuke Tateishi, Arata Takahashi, et al.
Liver Cancer|October 11, 2023
Proton Beam Therapy versus Radiofrequency Ablation for Patients with Treatment-Naïve Single Hepatocellular Carcinoma: A Propensity Score AnalysisYuta Sekino, Ryosuke Tateishi, Nobuyoshi Fukumitsu, et al.
Plos One|October 8, 2013
Changes in risk of immediate adverse reactions to iodinated contrast media by repeated administrations in patients with hepatocellular carcinomaNaoto Fujiwara, Ryosuke Tateishi, Masaaki Akahane, et al.
Scientific Reports|February 3, 2024
The impact of COVID-19 on the diagnosis and treatment of HCC: analysis of a nationwide registry for advanced liver diseases (REAL)Kazuya Okushin, Ryosuke Tateishi, Shinya Hirakawa, et al.
Journal of Hepatology|March 1, 2015
Sarcopenia, intramuscular fat deposition, and visceral adiposity independently predict the outcomes of hepatocellular carcinomaNaoto Fujiwara, Hayato Nakagawa, Yotaro Kudo, et al.
Journal of Gastroenterology and Hepatology|November 6, 2018
Liver stiffness measurements in chronic hepatitis C: Treatment evaluation and risk assessmentRyo Nakagomi, Ryosuke Tateishi, Ryota Masuzaki, et al.
Plos One|January 17, 2025
Retrospective evaluation of a novel ultrasound-based imaging analysis software for predicting radiofrequency ablation areasMasaya Sato, Ryosuke Tateishi, Yogev Zohar, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|May 30, 2025
Predicting the risk of developing diabetes in steatotic liver disease using controlled attenuation parameter in a health checkup populationTakuma Nakatsuka, Yutaka Yamaji, Ryosuke Tateishi, et al.
Pageof 7